LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Ex vivo and in vivo performance of anti-cancer drug loaded carbon nanotubes

Photo by kellysikkema from unsplash

Abstract In the present investigation we explore the ex vivo and in vivo cancer targeting potential of Doxorubicin laden oxidized dextran conjugated PEG-multi walled carbon nanotubes (DOX/ox-DEX/PEG-MWCNTs) using MCF-7 cells. The percent entrapment… Click to show full abstract

Abstract In the present investigation we explore the ex vivo and in vivo cancer targeting potential of Doxorubicin laden oxidized dextran conjugated PEG-multi walled carbon nanotubes (DOX/ox-DEX/PEG-MWCNTs) using MCF-7 cells. The percent entrapment efficiency was found to be 97.00 ± 2.10% (DOX/ox-DEX/PEG-MWCNTs) and 92.00± 3.00% (DOX/MWCNTs). The DOX/ox-DEX/PEG-MWCNTs depicted enhanced cellular uptake and cytotoxicity. The obtained results also showed the extended residence time of DOX/ox-DEX/PEG-MWCNTs as compared to DOX/MWCNTs and free DOX. Overall, we can conclude that the developed Doxorubicin loaded functionalized MWCNTs could be explored successfully for cancer targeting propensity.

Keywords: dex peg; peg mwcnts; carbon nanotubes; vivo vivo; dox dex; cancer

Journal Title: Journal of Drug Delivery Science and Technology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.